Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Hair thinning causes stem cell loss through a process involving Piezo1, calcium, and TNF-α.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

The hair serum significantly improved hair growth and reduced hair fall without causing any skin issues.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

To improve use of the contraceptive DMPA among adolescents, effectively manage side effects like menstrual changes and weight gain through counseling and guidance.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

The study identified the top 10 most important areas for future hair loss research.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

The Scalp Coverage Scoring method reliably measures hair density from images.

The herbal hair oil with natural extracts can improve hair health and reduce dandruff.

Unani medicine links diffuse hair loss to poor skin pore function and body dryness, leading to thinning hair.

The dog has Color Dilution Alopecia, causing hair loss and increased risk of skin infections.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

SMP is a medical tattoo for hair loss, improving appearance and camouflaging scars, but requires skill and has limitations.